LUMO - Lumos Pharma GAAP EPS of -$0.94 beats by $0.04 revenue of $0.4M beats by $0.38M August, 09 2022 04:02 PM Lumos Pharma Inc. Lumos Pharma press release ( NASDAQ: LUMO ): Q2 GAAP EPS of -$0.94 beats by $0.04 . Revenue of $0.4M (+3900.0% Y/Y) beats by $0.38M . For further details see: Lumos Pharma GAAP EPS of -$0.94 beats by $0.04, revenue of $0.4M beats by $0.38M